---
figid: PMC1914109__7601763f8
figlink: /pmc/articles/PMC1914109/figure/f8/
number: F8
caption: Schematic representation of the p110δ → RhoA → PTEN signalling pathway described
  in the text. p110x refers to class I PI3K isoforms other than p110δ. Indeed, the
  notion that inhibition of PTEN leads to increased PIP3/P-Akt in cells with inactive
  p110δ suggests that PTEN impinges on the PIP3 produced by the remaining active class
  I PI3K isoforms in these cells (p110α, p110β or p110γ). This implies that this pathway
  has the intrinsic capacity for indirect crosstalk between the class I PI3K isoforms.
pmcid: PMC1914109
papertitle: The p110δ isoform of PI 3-kinase negatively controls RhoA and PTEN.
reftext: Evangelia A Papakonstanti, et al. EMBO J. 2007 Jul 11;26(13):3050-3061.
pmc_ranked_result_index: '45714'
pathway_score: 0.9541404
filename: 7601763f8.jpg
figtitle: The p110D → RhoA → PTEN signalling pathway described in the text
year: '2007'
organisms:
- Homo sapiens
ndex: 053e53cf-debc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC1914109__7601763f8.html
  '@type': Dataset
  description: Schematic representation of the p110δ → RhoA → PTEN signalling pathway
    described in the text. p110x refers to class I PI3K isoforms other than p110δ.
    Indeed, the notion that inhibition of PTEN leads to increased PIP3/P-Akt in cells
    with inactive p110δ suggests that PTEN impinges on the PIP3 produced by the remaining
    active class I PI3K isoforms in these cells (p110α, p110β or p110γ). This implies
    that this pathway has the intrinsic capacity for indirect crosstalk between the
    class I PI3K isoforms.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - AKT2
  - SRC
  - AKT1
  - PTK2B
  - ARHGAP35
  - PTEN
  - CSF1R
  - C3
  - Y27632
  - H1152
  - Cancer
genes:
- word: Akt/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PYK2/Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: Akt/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PYK2/Src
  symbol: PYK2
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2B
  entrez: '2185'
- word: p190Rho-GAP
  symbol: p190RhoGAP
  source: hgnc_alias_symbol
  hgnc_symbol: ARHGAP35
  entrez: '2909'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CSF-1R
  symbol: CSF1R
  source: hgnc_symbol
  hgnc_symbol: CSF1R
  entrez: '1436'
- word: C3
  symbol: C3
  source: hgnc_symbol
  hgnc_symbol: C3
  entrez: '718'
- word: Akt/PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: Y27632
  source: MESH
  identifier: C108830
- word: H1152
  source: MESH
  identifier: C459092
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC1914109__F8
redirect_from: /figures/PMC1914109__F8
figtype: Figure
---
